Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A view from Europe.

¹Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Hospital, Gothenburg University, Sweden.

The American Journal of Cardiology

|December 21, 1992

Summary

This summary is machine-generated.

Certain beta-receptor antagonists and aspirin effectively prevent sudden cardiac death. Other cardiovascular drugs, like thiazide diuretics and calcium antagonists, do not reduce sudden cardiac death despite other benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.

Clinical pharmacology and therapeutics·2013

Same author

The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.

Journal of internal medicine·2013

Same author

The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.

Journal of internal medicine·2012

Same author

High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: experiences from very long-term follow-up in the AIR study.

Atherosclerosis·2009

Same author

Association between impaired glucose tolerance and carotid atherosclerosis: a study in 64-year-old women and a meta-analysis.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2008

Same author

Circulating oxidized LDL is associated with the occurrence of echolucent plaques in the carotid artery in 61-year-old men.

Scandinavian journal of clinical and laboratory investigation·2008

Area of Science:

Cardiology
Pharmacology
Clinical Trials

Background:

Coronary protection aims to prevent sudden death and myocardial infarction without increasing noncardiac mortality.
The efficacy of treating mild hypertension and hypercholesterolemia pharmacologically requires critical evaluation.
There is a need for robust, randomized clinical trials with definitive endpoints to assess cardioprotective capabilities.

Purpose of the Study:

To critically discuss the pharmacologic approaches to coronary protection.
To evaluate the effectiveness of various drug classes in preventing sudden cardiac death.
To emphasize the importance of well-designed clinical trials for determining cardioprotective effects.

Main Methods:

Review of existing randomized clinical trials with definitive endpoints.

Related Experiment Videos

Analysis of pharmacologic agents used for cardiovascular disease management.

Discussion of the pathophysiology of sudden cardiac death.

Main Results:

Some beta-receptor antagonists and aspirin have demonstrated protection against sudden cardiac death.
Thiazide diuretics, calcium antagonists, and angiotensin-converting enzyme inhibitors have not shown a reduction in sudden cardiac death.
Individual drugs within these classes may offer other cardiovascular benefits.

Conclusions:

Beta-receptor antagonists and aspirin are established agents for preventing sudden cardiac death.
The role of other drug classes in preventing sudden cardiac death remains unproven.
Pharmacokinetic differences among beta blockers may influence their cardioprotective effects.